Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypoglycemic Agents and Cytokines in PCOS
ChiCTR-IIR-16007901Phase 4Not yet recruiting
- Sponsor
- The 2nd Affiliated Hospital of Chongqing Medical University
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of metformin and pioglitazone in polycystic ovary syndrome (PCOS), sponsored by The 2nd Affiliated Hospital of Chongqing Medical University. Primary endpoint: Insulin resistance. Planned start Feb 2016; status: not yet recruiting.
02
Drugs
metforminpioglitazone
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on ChiCTR-IIR-16007901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-16007901.